flurbiprofen has been researched along with Corneal Neovascularization in 2 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Corneal Neovascularization: New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the efficacy of various combinations of flurbiprofen, low molecular weight heparin (LMWH), and doxycycline on the inhibition of corneal neovascularization in rats." | 7.73 | The effect of combinations of flurbiprofen, low molecular weight heparin, and doxycycline on the inhibition of corneal neovascularization. ( Aydin, E; Kazi, AA; Kivilcim, M; Peyman, GA; Riazi-Esfahani, M; Sanders, DR, 2006) |
| "To determine the efficacy of various combinations of flurbiprofen, low molecular weight heparin (LMWH), and doxycycline on the inhibition of corneal neovascularization in rats." | 3.73 | The effect of combinations of flurbiprofen, low molecular weight heparin, and doxycycline on the inhibition of corneal neovascularization. ( Aydin, E; Kazi, AA; Kivilcim, M; Peyman, GA; Riazi-Esfahani, M; Sanders, DR, 2006) |
| "To evaluate the effect of topically administered agents doxycycline, triamcinolone, low molecular weight heparin (LMWH), and flurbiprofen on experimental corneal neovascularization in rats." | 3.73 | Prevention of corneal neovascularization: evaluation of various commercially available compounds in an experimental rat model. ( Aydin, E; Kazi, AA; Kivilcim, M; Peyman, GA; Riazi-Esfahani, M; Sanders, DR, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peyman, GA | 2 |
| Kazi, AA | 2 |
| Riazi-Esfahani, M | 2 |
| Aydin, E | 2 |
| Kivilcim, M | 2 |
| Sanders, DR | 2 |
2 other studies available for flurbiprofen and Corneal Neovascularization
| Article | Year |
|---|---|
The effect of combinations of flurbiprofen, low molecular weight heparin, and doxycycline on the inhibition of corneal neovascularization.
Topics: Administration, Topical; Animals; Cornea; Corneal Neovascularization; Disease Models, Animal; Doxycy | 2006 |
Prevention of corneal neovascularization: evaluation of various commercially available compounds in an experimental rat model.
Topics: Animals; Anti-Bacterial Agents; Cornea; Corneal Neovascularization; Cyclooxygenase Inhibitors; Disea | 2006 |